176 related articles for article (PubMed ID: 34262084)
1. Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor.
Babcock MC; Mikulka CR; Wang B; Chandriani S; Chandra S; Xu Y; Webster K; Feng Y; Nelvagal HR; Giaramita A; Yip BK; Lo M; Jiang X; Chao Q; Woloszynek JC; Shen Y; Bhagwat S; Sands MS; Crawford BE
Sci Rep; 2021 Jul; 11(1):14486. PubMed ID: 34262084
[TBL] [Abstract][Full Text] [Related]
2. Modest phenotypic improvements in ASA-deficient mice with only one UDP-galactose:ceramide-galactosyltransferase gene.
Franken S; Wittke D; Mansson JE; D'Hooge R; De Deyn PP; Lüllmann-Rauch R; Matzner U; Gieselmann V
Lipids Health Dis; 2006 Aug; 5():21. PubMed ID: 16893448
[TBL] [Abstract][Full Text] [Related]
3. Genetic ablation of Saposin-D in Krabbe disease eliminates psychosine accumulation but does not significantly improve demyelination.
Watanabe T; Tsuboi K; Matsuda N; Ishizuka Y; Go S; Watanabe E; Ono A; Okamoto Y; Matsuda J
J Neurochem; 2023 Aug; 166(4):720-746. PubMed ID: 37337846
[TBL] [Abstract][Full Text] [Related]
4. Lysosulfatide (sulfogalactosylsphingosine) accumulation in tissues from patients with metachromatic leukodystrophy.
Toda K; Kobayashi T; Goto I; Ohno K; Eto Y; Inui K; Okada S
J Neurochem; 1990 Nov; 55(5):1585-91. PubMed ID: 1976756
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of lysosulfatide in the brain of arylsulfatase A-deficient mice.
Blomqvist M; Gieselmann V; Månsson JE
Lipids Health Dis; 2011 Feb; 10():28. PubMed ID: 21299873
[TBL] [Abstract][Full Text] [Related]
6. Myelination in the absence of UDP-galactose:ceramide galactosyl-transferase and fatty acid 2 -hydroxylase.
Meixner M; Jungnickel J; Grothe C; Gieselmann V; Eckhardt M
BMC Neurosci; 2011 Mar; 12():22. PubMed ID: 21366909
[TBL] [Abstract][Full Text] [Related]
7. A novel brain-penetrant oral UGT8 inhibitor decreases in vivo galactosphingolipid biosynthesis in murine Krabbe disease.
Zaccariotto E; Cachón-González MB; Wang B; Lim S; Hirth B; Park H; Fezoui M; Sardi SP; Mason P; Barker RH; Cox TM
Biomed Pharmacother; 2022 May; 149():112808. PubMed ID: 35290889
[TBL] [Abstract][Full Text] [Related]
8. Deletion of fatty acid amide hydrolase reduces lyso-sulfatide levels but exacerbates metachromatic leukodystrophy in mice.
Yaghootfam C; Gehrig B; Sylvester M; Gieselmann V; Matzner U
J Biol Chem; 2021 Sep; 297(3):101064. PubMed ID: 34375644
[TBL] [Abstract][Full Text] [Related]
9. Sulfatide storage in neurons causes hyperexcitability and axonal degeneration in a mouse model of metachromatic leukodystrophy.
Eckhardt M; Hedayati KK; Pitsch J; Lüllmann-Rauch R; Beck H; Fewou SN; Gieselmann V
J Neurosci; 2007 Aug; 27(34):9009-21. PubMed ID: 17715338
[TBL] [Abstract][Full Text] [Related]
10. Effects of sulfatide on peripheral nerves in metachromatic leukodystrophy.
Farah MH; Dali CÍ; Groeschel S; Moldovan M; Whiteman DAH; Malanga CJ; Krägeloh-Mann I; Li J; Barton N; Krarup C
Ann Clin Transl Neurol; 2024 Feb; 11(2):328-341. PubMed ID: 38146590
[TBL] [Abstract][Full Text] [Related]
11. Role of endogenous psychosine accumulation in oligodendrocyte differentiation and survival: implication for Krabbe disease.
Won JS; Kim J; Paintlia MK; Singh I; Singh AK
Brain Res; 2013 May; 1508():44-52. PubMed ID: 23438514
[TBL] [Abstract][Full Text] [Related]
12. LC-MS/MS assays to quantify sulfatides and lysosulfatide in cerebrospinal fluid of metachromatic leukodystrophy patients.
Cao KH; Zhang G; Jacobsen L; Wu J
Bioanalysis; 2020 Nov; 12(22):1621-1633. PubMed ID: 33151743
[No Abstract] [Full Text] [Related]
13. Accumulation of lysosulfatide (sulfogalactosylsphingosine) in tissues of a boy with metachromatic leukodystrophy.
Toda K; Kobayashi T; Goto I; Kurokawa T; Ogomori K
Biochem Biophys Res Commun; 1989 Mar; 159(2):605-11. PubMed ID: 2539117
[TBL] [Abstract][Full Text] [Related]
14. Biochemical pathogenesis of genetic leukodystrophies: comparison of metachromatic leukodystrophy and globoid cell leukodystrophy (Krabbe's disease).
Suzuki K
Neuropediatrics; 1984 Sep; 15 Suppl():32-6. PubMed ID: 6152811
[TBL] [Abstract][Full Text] [Related]
15. Biochemistry and neuropathology of mice doubly deficient in synthesis and degradation of galactosylceramide.
Ezoe T; Vanier MT; Oya Y; Popko B; Tohyama J; Matsuda J; Suzuki K; Suzuki K
J Neurosci Res; 2000 Jan; 59(2):170-8. PubMed ID: 10650875
[TBL] [Abstract][Full Text] [Related]
16. Study of pathogenesis in twitcher mouse, an enzymatically authentic model of Krabbe's disease.
Inui K; Nishimoto J; Taniike M; Midorikawa M; Tsukamoto H; Okada S; Yabuuchi H
J Neurol Sci; 1990 Dec; 100(1-2):124-30. PubMed ID: 2128519
[TBL] [Abstract][Full Text] [Related]
17. Lysosulfatide (galactosylsphingosine-3-O-sulfate) from metachromatic leukodystrophy and normal human brain.
Rosengren B; Fredman P; Månsson JE; Svennerholm L
J Neurochem; 1989 Apr; 52(4):1035-41. PubMed ID: 2926387
[TBL] [Abstract][Full Text] [Related]
18. Galactosylceramide and galactosylsphingosine loading studies in cultured skin fibroblasts in human and murine globoid cell leukodystrophy.
Ida H; Kusano K; Suzuki H; Tokoro T; Eto Y
Biochem Biophys Res Commun; 1990 Jan; 166(2):1053-60. PubMed ID: 2302222
[TBL] [Abstract][Full Text] [Related]
19. Genetic ablation of acid ceramidase in Krabbe disease confirms the psychosine hypothesis and identifies a new therapeutic target.
Li Y; Xu Y; Benitez BA; Nagree MS; Dearborn JT; Jiang X; Guzman MA; Woloszynek JC; Giaramita A; Yip BK; Elsbernd J; Babcock MC; Lo M; Fowler SC; Wozniak DF; Vogler CA; Medin JA; Crawford BE; Sands MS
Proc Natl Acad Sci U S A; 2019 Oct; 116(40):20097-20103. PubMed ID: 31527255
[TBL] [Abstract][Full Text] [Related]
20. Reversal of non-hydroxy:alpha-hydroxy galactosylceramide ratio and unstable myelin in transgenic mice overexpressing UDP-galactose:ceramide galactosyltransferase.
Fewou SN; Büssow H; Schaeren-Wiemers N; Vanier MT; Macklin WB; Gieselmann V; Eckhardt M
J Neurochem; 2005 Jul; 94(2):469-81. PubMed ID: 15998297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
